**Our vision** is to control the spread of infectious diseases by using viral-based technology to produce recombinant protein nanoparticle vaccines for viruses, bacteria, and parasites. We are dedicated to creating recombinant vaccines to address a broad range of infectious and chronic diseases.
The company is developing a portfolio of vaccine candidates targeting hepatitis B virus, and potentially hepatitis C and other viral agents. CaroGen, founded in 2012 and headquartered in the United States, received a $6.80M grant investment on 12 December 2023 from the U.S. Department of Defense. This innovative biopharmaceutical company aims to revolutionize vaccine development and make a significant impact in controlling and preventing infectious diseases globally.
CaroGen Corporation
Founded 2012
Farmington, United States
12 employees
Grant
Total: $11.35M
Biopharma, Biotechnology +2
Farmington, United States
12 employees
Grant
Total: $11.35M
Biopharma, Biotechnology +2
General Information
Get notified when CaroGen Corporation moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track CaroGen Corporation
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biopharma
About CaroGen Corporation
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 | •••• •••• | 12 Dec 2023 |
| Grant | •••••• | 1 | •••• •••• | 03 May 2021 |
| Grant | •••••• | 1 | •••• •••• | 27 Mar 2019 |
| Seed Round | •••••• | 1 |
|
08 Sep 2013 |
CaroGen Corporation Alternatives & Competitors
CaroGen Corporation vs
Advaccine
China
Advancing Vaccines，Improving Immunotherapeutics
Private Equity
5 employees
Biopharma, Biotechnology
CaroGen Corporation vs
Dynavax Technologies
United States
Dynavax, a Sanofi Company, is a commercial-stage biopharmaceutical company developing and commercial...
297 employees
CaroGen Corporation vs
Hawaii Biotech, Inc.
United States
Hawaii Biotech, Inc. (HBI) is a privately held biotechnology company focused on the research and dev...
Grant
15 employees
Biotechnology, Health Care
FAQ About CaroGen Corporation
CaroGen Corporation is an emerging biopharmaceutical company with an entirely new vaccine platform technology developed at Yale University School of Medicine.
The Company has recently executed an exclusive license with Yale University to the replication proficient virus-like vesicle (VLV) a plat...
CaroGen Corporation was founded in 2012.
CaroGen Corporation is headquartered in Farmington, United States.
CaroGen Corporation operates in the following industries: Biopharma, Biotechnology, Health Care, Pharmaceutical.
CaroGen Corporation has approximately 12 employees.
CaroGen Corporation has completed 4 funding rounds, raising a total of $11.35M. The latest funding stage is Grant.
Top alternatives and competitors to CaroGen Corporation include Advaccine, Dynavax Technologies, Hawaii Biotech, Inc., Pacific Genetech, Greffex, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CaroGen Corporation and Advaccine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors CaroGen Corporation and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
